Core Scientific (CORZ) Accumulated Expenses (2020 - 2026)

Core Scientific has disclosed Accumulated Expenses across 7 years of filings, most recently posting $364.5 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $364.5 million, up 281.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $364.5 million (up 281.69% YoY), and the FY2025 annual result was $512.0 million, up 691.65% from the prior year.
• Accumulated Expenses came in at $364.5 million for Q1 2026 at Core Scientific, down from $512.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $512.0 million in Q4 2025 to a low of $18.0 million in Q4 2022.
• The 5-year median for Accumulated Expenses is $72.8 million (2022), against an average of $138.0 million.
• Peak annual rise in Accumulated Expenses reached 10417.75% in 2022, while the deepest fall reached 73.55% in 2022.
• Core Scientific's Accumulated Expenses stood at $18.0 million in 2022, then soared by 900.65% to $179.6 million in 2023, then plunged by 64.0% to $64.7 million in 2024, then soared by 691.65% to $512.0 million in 2025, then decreased by 28.81% to $364.5 million in 2026.
• The last three Accumulated Expenses figures came in at $364.5 million (Q1 2026), $512.0 million (Q4 2025), and $358.3 million (Q3 2025), per Business Quant data.